Treatment at 15 mg/kg also resulted in a decrease of T turn and T total times, but these did not reach statistical significance.
← all excerpts
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.
1
—
—